Business Context and Reporting Period
Company: Focus Universal Inc. (FCUV)
Filing Type: Form 8-K (Current Report)
Date of Report: May 15, 2026
Reporting Period: Events occurring through May 15, 2026, with signature date May 26, 2026.
Primary Purpose: To disclose compliance with Nasdaq Capital Market continued listing standards (Equity Rule 5550(b)(1)) following specific capital transactions.
Key Financial Metrics and Capital Structure
The filing focuses on capital structure changes rather than operational financial performance. Key metrics include:
- Stockholders' Equity: The Company asserts it now holds at least $2.5 million, meeting the Nasdaq minimum requirement.
- Preferred Stock Redemption: $961,860 paid to redeem remaining Series B Convertible Preferred Stock held by Great Point Capital LLC.
- Private Placement Proceeds: $4,000,000 raised via a warrant offering with Armistice Capital Master Fund Ltd.
- Debt and Liquidity: The filing text does not provide specific values for total debt, cash flow, or current liquidity ratios.
- Revenue and Profit: The filing text does not provide revenue, profit, or margin data.
Material Changes Versus Prior Period
Significant changes in equity composition occurred between the prior reporting period and May 15, 2026:
- Series B Conversion: On or about April 6, 2026, 5,216 shares of Series B Convertible Preferred Stock were converted into 665,328 shares of Common Stock.
- Series B Redemption: On April 13, 2026, the remaining Series B shares were redeemed for $961,860. As of the May 14, 2026 Form 10-Q, no Series B Preferred Stock remains outstanding.
- Warrant Exercise: Following a $4 million private placement closed on April 10, 2026, the investor (Armistice) exercised a Pre-Funded Warrant in its entirety by May 15, 2026, converting it into 1,117,318 shares of Common Stock.
Outlook, Risks, and Management Commentary
Management Commentary: Management states that the completion of the Series B Conversion, the redemption of remaining preferred shares, and the full exercise of the Pre-Funded Warrants have restored the Company's stockholders' equity to the required $2.5 million threshold.
Compliance Status: The Company believes it is currently in compliance with Nasdaq's listing standards.
Risks and Contingencies: The filing does not explicitly detail new risks or contingencies beyond the prior risk of delisting due to insufficient equity, which has been addressed by the capital transactions described.
Investor Verification Checklist
- Verify the exact stockholders' equity balance in the most recent Form 10-Q (filed May 14, 2026) to confirm the $2.5 million threshold.
- Confirm the total number of Common Stock shares outstanding post-conversion and post-warrant exercise to assess dilution impact.
- Review the terms of the Series A and Series B Common Warrants issued to Armistice (exercise price $3.33, expiring in 24 and 60 months respectively) for future dilution risks.
- Check for any subsequent Nasdaq communications regarding the Company's compliance status.